Report Overview
Endothelial keratoplasty (EK) is a cornea transplant technique that is the preferred way to restore vision when the inner cell layer of the cornea stops working properly from Fuchs dystrophy, bullous keratopathy, iridocorneal endothelial (ICE) syndrome, or other endothelial disorders. EK selectively replaces only the diseased layer of the cornea, leaving healthy areas intact.
www.reallygreatsite.com
Market Share
The global Endothelial Keratoplasty (EK) market size was estimated at USD 98 million in 2023 and is projected to reach USD 458.44 million by 2032, exhibiting a CAGR of 18.70% during the forecast period.
North America Endothelial Keratoplasty (EK) market size was estimated at USD 34.38 million in 2023, at a CAGR of 16.03% during the forecast period of 2025 through 2032.
Key Company
• Mayo Clinic
• Cellusion
• LaserVision
• Precise Bio
• Altomed
• CorneaGen
Market Segmentation
• Descemet's Stripping Endothelial Keratoplasty (DSEK)
• Descemet's Membrane Endothelial
Keratosplaty (DMEK)
By Application
• Adults
• Children
Geographic Segmentation
•North America: USA, Canada, Mexico
•Europe: Germany, UK, France, Russia, Italy, Rest of Europe
•Asia-Pacific: China, Japan, South Korea, India, SoutheastAsia, Rest ofAsia-Pacific
•South America: Brazil, Argentina, Colombia, Rest of SouthAmerica
•Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
